Wellgistics Health, Inc. (WGRX) Financial Statements (2026 and earlier)

Company Profile

Business Address 3000 BAYPORT DRIVE SUITE 950
TAMPA, FL 33607
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments431,028
Cash and cash equivalent431,028
Receivables  
Inventory, net of allowances, customer advances and progress billings1,6399,519
Inventory1,6399,519
Prepaid expense  1
Deferred costs  875
Other undisclosed current assets 1,1373,746
Total current assets:2,81915,169
Noncurrent Assets
Operating lease, right-of-use asset9671,528
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization229388
Long-term investments and receivables  157
Long-term investments  18
Accounts and financing receivable, after allowance for credit loss  140
Intangible asset, including goodwill, after accumulated amortization16,69317,838
Goodwill14,19416,220
Intangible asset, excluding goodwill, after accumulated amortization2,5001,618
Deferred costs 875 
Other noncurrent assets  1,421
Other undisclosed noncurrent assets8,87520,831
Total noncurrent assets:27,64042,164
TOTAL ASSETS:30,45957,333
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities948852
Accrued liabilities948852
Debt10,88811,928
Other undisclosed current liabilities17,94525,267
Total current liabilities:29,78038,047
Noncurrent Liabilities
Long-term debt and lease obligation12,60055
Long-term debt, excluding current maturities12,60055
Liabilities, other than long-term debt5271,096
Operating lease, liability5271,096
Other undisclosed noncurrent liabilities  11,400
Total noncurrent liabilities:13,12712,551
Total liabilities:42,90750,598
Equity
Equity, attributable to parent(12,448)6,734
Common stock105
Additional paid in capital98,57416,487
Accumulated deficit(111,032)(9,757)
Total equity:(12,448)6,734
TOTAL LIABILITIES AND EQUITY:30,45957,333

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
Revenues23,33818,129
Cost of revenue(29,764)(16,362)
Cost of product and service sold (5,988) 
Gross profit:(6,426)1,767
Operating expenses(87,323)(7,912)
Operating loss:(93,749)(6,145)
Nonoperating expense(7,525)(711)
Other nonoperating income42120
Interest and debt expense(2,988)(831)
Loss from continuing operations before equity method investments, income taxes:(104,262)(7,688)
Other undisclosed income from continuing operations before income taxes2,988831
Net loss available to common stockholders, diluted:(101,275)(6,856)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
Net loss:(101,275)(6,856)
Comprehensive loss, net of tax, attributable to parent:(101,275)(6,856)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: